Advisers to the Centers for Disease Control and Prevention endorsed a booster plan Thursday for all three COVID-19 vaccines, nudging forward a strategy to let Americans mix-and-match brands to not only bolster their defenses but avoid rare, though serious, side effects that have been linked to both vaccine technologies deployed in the U.S.